1. 115 MDS-005 STUDY: EFFECT OF BASELINE ENDOGENOUS EPO ON RBC TRANSFUSION INDEPENDENCE (RBC-TI) IN LENALIDOMIDE-TREATED PATIENTS WITH LOW/INTERMEDIATE-1-RISK MDS WITHOUT DEL(5Q). (April 2015) Authors: Santini, V.; Li, J.S.; Swern, A.S.; Almeida, A.; Giagounidis, A.; Fu, T.; Hoenekopp, A.; Beach, C.L.; Skikne, B.; Fenaux, P. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 116 THE EFFECT OF LENALIDOMIDE ON HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN PATIENTS WITH MDS: RESULTS FROM THE MDS-005 TRIAL. (April 2015) Authors: Santini, V.; Almeida, A.; Giagounidis, A.; Bartiromo, C.; Hoenekopp, A.; Guo, S.; Beach, C.L.; Altincatal, A.; Wu, C.; Skikne, B.; Zhong, J.; Hu, X.H.; Fenaux, P. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 117 A PHASE 3 STUDY OF LENALIDOMIDE VERSUS PLACEBO IN RBC TRANSFUSION-DEPENDENT (TD) PATIENTS WITH LOWER-RISK MDS WITHOUT DEL(5Q) UNRESPONSIVE OR REFRACTORY TO ERYTHROPOIESIS-STIMULATING AGENTS (ESAS). Issue 1 (April 2015) Authors: Santini, V.; Almeida, A.; Giagounidis, A.; Gröpper, S.; Jonasova, A.; Vey, N.; Mufti, G.J.; Buckstein, R.; Mittelman, M.; Platzbecker, U.; Shpilberg, O.; Ram, R.; del Canizo, C.; Gattermann, N.; Ozawa, K.; Risueno, A.; MacBeth, K.J.; Zhong, J.; Séguy, F.; Hoenekopp, A. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 124 AZACITIDINE VERSUS CONVENTIONAL CARE REGIMENS (CCR) IN OLDER PATIENTS WITH NEWLY DIAGNOSED AML (>30% MARROW BLASTS) WITH MYELODYSPLASIA-RELATED CHANGES: SUBGROUP ANALYSIS OF THE AZA-AML-001 STUDY. (April 2015) Authors: Seymour, J.F.; Döhner, H.; Butrym, A.; Wierzbowska, A.; Selleslag, D.; Jang, J.H.; Cavenagh, J.D.; Kumar, R.; Schuh, A.C.; Candoni, A.; Récher, C.; Sandhu, I.; del Castillo, T. Bernal; Al-Ali, H.K.; Martinelli, G.; Falantes, J.; Nopenney, R.; Stone, R.M.; Minden, M.D.; McIntyre, H. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 57 A PHASE 2 MULTICENTER STUDY OF CC-486 (ORAL AZACITIDINE) IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) WHO FAIL TO ACHIEVE RESPONSE WITH INJECTABLE AZACITIDINE OR DECITABINE. (April 2015) Authors: Garcia-Manero, G.; Silverman, L.R.; Komrokji, R.S.; Mufti, G.J.; Seymour, J.F.; Tsai, K.; Reiser, D.; Skikne, B.S.; Beach, C.L.; Fenaux, P. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 96 OVERALL SURVIVAL IN OLDER PATIENTS WITH NEWLY DIAGNOSED AML WITH >30% BONE MARROW BLASTS AND POOR-RISK CYTOGENETICS TREATED WITH AZACITIDINE: SUBANALYSIS OF THE AZA-AML-001 STUDY. (April 2015) Authors: Döhner, H.; Seymour, J.F.; Butrym, A.; Wierzbowska, A.; Selleslag, D.; Jang, J.H.; Cavenagh, J.D.; Kumar, R.; Schuh, A.C.; Candoni, A.; Récher, C.; Sandhu, I.; del Castillo, T. Bernal; Al-Ali, H.K.; Martinelli, G.; Falantes, J.; Nopenney, R.; Stone, R.M.; Minden, M.D.; McIntyre, H. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Azacitidine Prolongs Overall Survival in Older Patients with Acute Myeloid Leukemia (AML) with Poor Prognostic Karyotypes. (April 2017) Authors: Döhner, H.; Vyas, P.; Seymour, J.F.; Santini, V.; Stone, R.M.; Minden, M.D.; Al-Ali, H.K.; del Castillo, T. Bernal; Morrill, J.; Songer, S.; Weaver, J.; Skikne, B.S.; Beach, C.L.; Dombret, H. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Azacitidine Versus Conventional Care Regimens (CCR) in Elderly Patients (≥75 Years) with Acute Myeloid Leukemia (AML) in the AZA-AML-001 Study. (April 2017) Authors: Seymour, J.F.; Buckstein, R.; Santini, V.; Döhner, H.; Stone, R.M.; Minden, M.D.; Kuo, C.Y.; Ben-Yehuda, D.; Bargay, J.; Songer, S.; Weaver, J.; Beach, C.L.; Dombret, H. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Efficacy, safety and pharmacokinetics of subcutaneous azacitidine in Chinese patients with higher risk myelodysplastic syndromes: Results from a multicenter, single‐arm, open‐label phase 2 study. Issue 3 (28th December 2017) Authors: Du, Xin; Lai, Yue‐Yun; Xiao, Zhijian; Liu, Ting; Hu, Yu; Sun, Aining; Li, Xiao; Shen, Zhi‐Xiang; Jin, Jie; Yu, Li; Laille, Eric; Dong, Qian; Songer, Stephen; Beach, C.L. Journal: Asia-Pacific journal of clinical oncology Issue: Volume 14:Issue 3(2018) Page Start: 270 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Impact of Gene Mutations on Response to Lenalidomide and OS in Lower-Risk Non-Del(5Q) MDS Patients Ineligible/Refractory to Erythropoiesis-Stimulating Agents (ESAS). (April 2017) Authors: Santini, V.; Fenaux, P.; Giagounidis, A.; Platzbecker, U.; Almeida, A.; List, A.F.; Zhong, J.; Wu, C.; Mavrommatis, K.; Beach, C.L.; MacBeth, K.J. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗